SPY458.97-10.47 -2.23%
DIA349.02-9.01 -2.52%
IXIC15,491.66-353.57 -2.23%

Roth Capital Initiates Coverage On Mydecine Innovations with Buy Rating, Announces Price Target of C$3

Roth Capital analyst Elemer Piros initiates coverage on Mydecine Innovations (NEO: MYCO) with a Buy rating and announces Price Target of C$3.

Benzinga · 06/22/2021 09:03
Roth Capital analyst Elemer Piros initiates coverage on Mydecine Innovations (NEO: MYCO) with a Buy rating and announces Price Target of C$3.